Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Breast Cancer Reports
Published in: Current Breast Cancer Reports 2/2016

Open Access 01-06-2016 | Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

Oncoplastic Breast Surgery: What, When and for Whom?

Authors: R. Douglas Macmillan, Stephen J. McCulley

Published in: Current Breast Cancer Reports | Issue 2/2016

Login to get access

Abstract

Oncoplastic surgery is integral to all breast cancer surgeries. The use of an aesthetic approach to breast conservation or mastectomy greatly enhances the range of options that can be offered to women with breast cancer and facilitates better outomes from it. It should be the standard of care. However, a structured approach to selecting appropriate techniques is essential, and although many operative procedures are reported, this article sets out to describe a set of principles and an algorithm by which the what, when and for whom for oncoplastic surgery can be defined.
Literature
1.
Audretsch W, Rezai M, Kolotas C, et al. Tumour-specific immediate reconstruction in breast cancer patients. Semin Plastic Surg. 1998;11:71–99. An approach to the repair of partial mastectomy defects.CrossRef
2.
Petit JY, Rigaut L, Zekri A, Le M. Poor esthetic results after conservative treatment of breast cancer. Technics of partial breast reconstruction. [French]. Ann Chir Plast Esthet. 1989;34(2):103–8.PubMed
3.
Clough KB, Kroll SS, Audretsch W. An approach to the repair of partial mastectomy defects. Plastic & Reconstructive Surgery. 1999;104(2):409–20.CrossRef
4.
Clough KB, Lewis JS, Couturaud B, et al. Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Ann Surg. 2003;237:26–34.CrossRefPubMedPubMedCentral
5.
McCulley SJ, Macmillan RD. Planning and use of therapeutic mammoplasty—Nottingham approach. Br J Plast Surg. 2005;58(7):889–901.CrossRefPubMed
6.
Rainsbury RM. Oncoplastic breast-conserving reconstruction: indications, benefits, choices and outcomes. Nat Clin Pract Oncol. 2007;4:657–64.CrossRefPubMed
7.
Hamdi M, Van Landuyt K, de Frene B, Roche N, Blondeel P, Monstrey S. The versatility of the inter-costal artery perforator (ICAP) flaps. J Plast Reconstr Aesthet Surg. 2006;59(6):644–52.CrossRefPubMed
8.
Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati IM. Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol. 2010;17(5):1375–91.CrossRefPubMed
9.
Macmillan RD. Mastectomy for Breast Cancer: Tips and Pitfalls. In Companion to Specialist Surgical Practices. Ed Dixon M. 2014.
10.
Endara M, Chen D, Verma K, Nahabedian MY, Spear SL. Breast reconstruction following nipple-sparing mastectomy: a systematic review of the literature with pooled analysis. Plast and Reconstr Surg. 2013;132:1043.CrossRef
11.
Wei CH, Scott AM, Price AN, Miller HC, Klassen AF, Jhanwar SM, et al. Psychosocial and sexual well-being following nipple-sparing mastectomy and reconstruction. Breast J. 2016;22(1):10–7.CrossRefPubMed
12.
Didier F, Radice D, Gandini S, Bedolis R, Rotmensz N, Maldifassi A, et al. Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality? Breast Cancer Res Treat. 2009;118(3):623–33.CrossRefPubMed
13.
Cochrane RA, Valassiadou P, Wilson ARM, Al-Ghazal SK, Macmillan RD. Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. Br J Surg. 2003;90:1505–9.CrossRefPubMed
14.
Lyngholm CD, Christiansen PM, Damsgaard TE, Overgaard J. Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncol. 2013;52:359–269.CrossRef
15.
Waljee JF, Hu ES, Ubel PA, Smith DM, Newman LA, Alderman AK. Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol. 2008;26(20):3331–7.CrossRefPubMed
16.
Al-Ghazal SK, Blamey RW, Stewart J, Morgan AAL. The cosmetic outcome in early breast cancer treated with breast conservation. Eur J Surg Oncol. 1999;25(6):566–70.CrossRefPubMed
17.
Moody AM, Mayles WPM, Bliss JM, et al. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol. 1994;33(2):106–12.CrossRefPubMed
18.
Neal AJ, Torr M, Helyer S, Yarnold JR. Correlation of breast dose heterogeneity with breast size using 3D CT planning and dose volume histograms. Radiother Oncol. 1995;34:210–8.CrossRefPubMed
19.
Goldsmith C, Haviland J, Tsang Y, et al. Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation? Radiother Oncol. 2011;109:236–40.CrossRef
20.
Palmieri B, Benuzzi G, Costa A, Grappolini S. Breast reduction and subsequent cancer: a prophylactic perspective. Breast. 2006;15:476–81.CrossRefPubMed
21.
Macmillan RD, Chan CW, McCulley SJ. Volume displacement techniques
22.
James R, McCulley SJ, Macmillan RD. Oncoplastic and Reconstructive Surgery in the Elderly. Br J Surg. 2015;102(5):480–8.CrossRefPubMed
23.
Macmillan RD, James R, Gale KL, McCulley SJ. Therapeutic mammaplasty. J Surg Oncol. 2014;110:90–5.CrossRefPubMed
24.
Benelli L. A new periareolar mammaplasty: the “round block” technique. Aesthetic Plast Surg. 1990;14(2):93–100.CrossRefPubMed
25.
Silverstein MJ, Mai T, Savalia N, Vaince F, Guerra L. Oncoplastic breast conservation surgery: the new paradigm. J Surg Oncol. 2014;110(1):82–9.CrossRefPubMed
26.
Hamdi M, Spano A, Van Landuyt K, D’Herde K, Blondeel P, Monstrey S. The lateral intercostal artery perforators: anatomical study and clinical application in breast surgery. Plast Reconstr Surg. 2008;121:389e96.CrossRef
27.
McCulley SJ, Schaverien MV, Tan VK, Macmillan RD. Lateral thoracic artery perforator (LTAP) flap in partial breast reconstruction. J Plast Reconstr Aesthet Surg. 2015;68(5):686–91.CrossRefPubMed
28.
Rusby JE, Paramanathan N, Laws SA, Rainsbury RM. Immediate latissimus dorsi miniflap volume replacement for partial mastectomy: use of intra-operative frozen sections to confirm negative margins. Am J Surg. 2008;196(4):512–8.CrossRefPubMed
29.
Zaha H, Onomura M, Nomura H, Umekawa K, Oki M, Asato H. Free omental flap for partial breast reconstruction after breast-conserving surgery. Plast Reconstr Surg. 2012;129(3):583–7.CrossRefPubMed
30.
Ogaw T, Hanamura N, Yamashita M, Ito M, Kimura H, Nakamura T, et al. Abdominal advancement flap as oncoplastic breast conservation: report of seven cases and their cosmetic results. J Breast Cancer. 2013;16(2):236–43.CrossRef
31.
Biazus JV, Falcão CC, Parizotto AC, Stumpf CC, Cavalheiro JA, Schuh F, et al. Immediate Reconstruction with Autologous fat Transfer Following Breast-Conserving Surgery. Breast J. 2015;21(3):268–75.CrossRefPubMed
32.
McCulley SJ, Macmillan RD, Rasheed T. Transverse Upper Gracilis (TUG) flap for volume replacement in breast conserving surgery for medial breast tumours in small to medium sized breasts. J Plast Reconstr Aesthet Surg. 2011;64(8):1056–60.CrossRefPubMed
33.
Peled AW, Sbitany H, Foster RD, Esserman LJ. Oncoplastic mammoplasty as a strategy for reducing reconstructive complications associated with postmastectomy radiation therapy. Breast J. 2014;20:302–7.CrossRefPubMed
34.
Wang F, Peled AW, Chin R, Fowble B, Alvarado M, Ewing C, et al. The impact of radiation therapy, lymph node dissection, and hormonal therapy on outcomes of tissue expander—implant exchange in prosthetic breast reconstruction. Plast Reconstr Surg. 2016;137(1):1–9.CrossRefPubMed
35.
Al-Ghazal SK, Fallowfield L, Blamey RW. Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Oncol. 1999;25(6):571–3.CrossRefPubMed
36.
Deshields TL, Reschke A, Walker MS, Brewer A, Taylor M. Psychological status at time of diagnosis and patients’ ratings of cosmesis following radiation therapy for breast cancer. J Psychosoc Oncol. 2007;25(2):103–16.CrossRefPubMed
Metadata
Title
Oncoplastic Breast Surgery: What, When and for Whom?
Authors
R. Douglas Macmillan
Stephen J. McCulley
Publication date
01-06-2016
Publisher
Springer US
Published in
Current Breast Cancer Reports / Issue 2/2016
Print ISSN: 1943-4588
Electronic ISSN: 1943-4596
DOI
https://doi.org/10.1007/s12609-016-0212-9

Other articles of this Issue 2/2016

Current Breast Cancer Reports 2/2016 Go to the issue

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

Margins in Breast-Conserving Surgery for Early Breast Cancer: How Much is Good Enough?

Biomarkers (S Dawood, Section Editor)

Emerging Biomarkers of the Future: Changing Clinical Practice for 2020

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

New Developments in Assessing Risk of Local Recurrence in Patients with Ductal Carcinoma In Situ after Lumpectomy and Breast Radiation

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

Regional Nodal Radiotherapy in Early-Stage Breast Cancer: Where Are We in 2016?

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

The Optimal Approach to Post-Mastectomy and Post-Lumpectomy Breast Reconstruction

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

Nipple-Sparing Mastectomy in Patients with Germline BRCA Mutations: Is it Safe?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits